title: Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer.
abstract: With the proven overall benefit of neoadjuvant chemotherapy in patients with locally advanced gastric cancer, there has come a need to discriminate responders from non-responders. In this article, the current role of anatomical and molecular imaging in the prediction of response to neoadjuvant therapy in gastric cancer is outlined and future prospects are discussed.
authors.affiliation: Robert Michael Kwee, Department of Radiology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
authors.forename: Robert Michael
authors.initials: RM
authors.lastname: Kwee
authors.affiliation: Robert Michael Kwee, Department of Radiology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
authors.forename: Thomas Christian
authors.initials: TC
authors.lastname: Kwee
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant / Q000379:methods*; D038524:Diffusion Magnetic Resonance Imaging; D019788:Fluorodeoxyglucose F18 / Q000737:chemistry; D006801:Humans; D008279:Magnetic Resonance Imaging; D057054:Molecular Imaging; D020360:Neoadjuvant Therapy / Q000379:methods*; D049268:Positron-Emission Tomography; D013274:Stomach Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D019788:Fluorodeoxyglucose F18
keywords: Chemotherapy; Gastric cancer; Imaging; Neoadjuvant therapy; Response